wellaray glp-1 probiotic Pro and our Muscle Guard Protein GLP-1 Probiotic Pro (Final Sale)

All three are also indicated for diabetes under different names and dosing schedules, which can be confusing (see the table GLP Agonists for Obesity)

Not indicated for use in patients with type 1 diabetes mellitus

A 2024 Mayo Clinic study found that postmenopausal women on hormone therapy experienced about 30% greater weight loss with semaglutide compared to those not on hormone therapy

This careful progression is essential for managing tolerability

Importantly, the review also notes that individual responses to incretin-based therapies can vary substantially, and weight regain commonly occurs if treatment is discontinued, highlighting the chronic nature of obesity management

Rising prevalence of obesity 3.3.1.2